Investment
Features
FeesSafety
Academy
More
Pluang+

Sono-Tek reports 6% revenue growth and 41% operating income rise in H1 2027, driven by medical sector surge.

Company Fundamentals
14 Oct 2026
GlobeNewsWire
View Source
Bullish
Sono-Tek reports 6% revenue growth and 41% operating income rise in H1 2027, driven by medical sector surge.

Sono-Tek Corporation posted a 6% increase in revenue to $10.9 million and a 41% rise in operating income to $1.28 million for the first half of fiscal 2027, led by a 289% surge in medical market sales. Gross margin expanded to 55%, reflecting a favorable product mix. The company expects flat to modest revenue growth for the full year due to timing of large orders but has strong order backlog and cash reserves, positioning it well for future growth. Medical device demand, especially for balloon and stent-coating systems, remains the key growth driver.

Sono-Tek's fiscal 2027 first half results provide context for healthcare sector interest. For readers following health stocks, here is Pluang's market snapshot as of Oct 14, 2026 18:11 WIB: Among 150 priced US health-sector stocks, 103 rose and 40 fell. ClearPoint Neuro Inc (CLPT) gained 3.36% to USD 10.14 with 100% buy orders and a typical hold time of 10 days, while Guardant Health Inc (GH) dropped 2.40% to USD 158.20 despite 100% buy orders and a shorter hold time of 3 days. Arrowhead Pharmaceuticals Inc (ARWR) rose 2.25% to USD 59.44 with a typical hold of 5 days.

More News

Genesis Global wins Best AI Solution for Software Development at 2026 AI in Capital Markets Awards

Genesis Global wins Best AI Solution for Software Development at 2026 AI in Capital Markets Awards

Genesis Global won the Best AI Solution for Software Development award at the 2026 AI in Capital Markets Awards for its product Genesis Create. This software combines AI with reusable components and financial expertise to help firms develop productio...

Others
Bullish
20 minutes ago
nuVizz named Accelerator in 2026 Nucleus Research TMS Value Matrix for last-mile delivery tech

nuVizz named Accelerator in 2026 Nucleus Research TMS Value Matrix for last-mile delivery tech

nuVizz has been recognized as an Accelerator in the 2026 Nucleus Research Transportation Management Value Matrix for its specialized last-mile delivery technology. The platform excels in coordinating complex delivery networks involving private fleets...

Market News
Bullish
20 minutes ago
ASML reports strong Q3 2026 EPS of $14.65 on high chip equipment demand despite slight revenue miss.

ASML reports strong Q3 2026 EPS of $14.65 on high chip equipment demand despite slight revenue miss.

ASML Holding posted a strong Q3 2026 earnings per share of $14.65, beating estimates of $12.17, driven by a 55% year-over-year sales growth and a 57.5% gross margin. Although revenue was slightly below expectations at $13.05 billion, the company bene...

Company Fundamentals
Bullish
1 hour ago
Charles Schwab Q3 earnings expected to rise on strong trading and asset management revenue.

Charles Schwab Q3 earnings expected to rise on strong trading and asset management revenue.

Charles Schwab is set to report its Q3 2026 earnings with an estimated EPS of $1.66 and revenue around $7.18-$7.19 billion, reflecting significant growth driven by an 18.2% increase in trading revenue, net interest income, and asset management fees. ...

Company Fundamentals
Bullish
1 hour ago
TSOs prioritize software investments to boost grid security and capacity amid rising demand

TSOs prioritize software investments to boost grid security and capacity amid rising demand

Transmission System Operators (TSOs) are increasingly investing in software like Energy Management Systems and grid planning tools to modernize aging infrastructure, enhance cybersecurity, and expand grid capacity. Cybersecurity remains their top con...

Market News
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App